Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury

Ken Shinmura, Masato Tani, Yukako Suganuma, Hiroshi Hasegawa, Yoshinori Ebihara, Yoshiro Nakamura, Yasushi Asakura

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

To clarify the roles of subclasses of α1-adrenoreceptors in ischemic- reperfused myocardium, we compared the effect of the nonselective α1- blocker bunazosin with that of the α(1A)-blocker WB4101 and the α(1B)- blocker chlorethylclonidine (CEC) in isolated rat hearts. After 30 min of preperfusion, Langendorff-perfused hearts were subjected to 25 min of global ischemia followed by 30 min of reperfusion. Hearts were randomly divided into 4 groups, with one of the following substances being added to the perfusate: buffer alone (control), 10-6 mol/L bunazosin, 10-7 mol/L WB4101, or 10- 7 mol/L CEC. Bunazosin had a negative inotropic effect and preserved the postischemic ATP content, reduced the postischemic increase in intracellular Na+ content and then enhanced postreperfusion recovery of creatine phosphate. Bunazosin also reduced myocardial 45Ca2+ uptake during reperfusion (control 5.2 vs bunazosin 2.5 μmol/g dry weight of tissue (dwt), p<0.01). However, the recovery of left ventricular developed pressure (DP) was not improved when bunazosin was added to the perfusate during reperfusion. WB4101 had neither a negative inotropic nor an energy-sparing effect, but it improved the recovery of DP (control 43% vs WB4101 56% of preischemic value, p<0.05) with no reduction in myocardial 45Ca2+ uptake. CEC had a negative inotropic and energy-sparing effect and then reduced myocardial 45Ca2+ uptake (CEC 3.1 μmol/g dwt, p<0.05), but it did not improve the recovery of DP. These results suggest that the preischemic administration of an α(1B)-adrenoreceptor subtype blocker protected ischemic-reperfused myocardium via reduction of Ca2+ overload, whereas the selective blockade of the α(1A)-adrenoreceptor subtype reduced myocardial damage via mechanism(s) other than Ca2+ metabolism.

Original languageEnglish
Pages (from-to)927-935
Number of pages9
JournalJapanese Circulation Journal
Volume61
Issue number11
DOIs
Publication statusPublished - 1997 Nov

Fingerprint

Reperfusion Injury
Reperfusion
Myocardium
Pressure
Weights and Measures
Phosphocreatine
Ventricular Pressure
bunazosin
Buffers
Ischemia
Adenosine Triphosphate
chlorethylclonidine
(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane

Keywords

  • α-Adrenoreceptors
  • α-Subtype
  • Ca overload
  • Myocardial ischemia
  • Reperfusion injury

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology

Cite this

Shinmura, K., Tani, M., Suganuma, Y., Hasegawa, H., Ebihara, Y., Nakamura, Y., & Asakura, Y. (1997). Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury. Japanese Circulation Journal, 61(11), 927-935. https://doi.org/10.1253/jcj.61.927

Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury. / Shinmura, Ken; Tani, Masato; Suganuma, Yukako; Hasegawa, Hiroshi; Ebihara, Yoshinori; Nakamura, Yoshiro; Asakura, Yasushi.

In: Japanese Circulation Journal, Vol. 61, No. 11, 11.1997, p. 927-935.

Research output: Contribution to journalArticle

Shinmura, K, Tani, M, Suganuma, Y, Hasegawa, H, Ebihara, Y, Nakamura, Y & Asakura, Y 1997, 'Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury', Japanese Circulation Journal, vol. 61, no. 11, pp. 927-935. https://doi.org/10.1253/jcj.61.927
Shinmura K, Tani M, Suganuma Y, Hasegawa H, Ebihara Y, Nakamura Y et al. Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury. Japanese Circulation Journal. 1997 Nov;61(11):927-935. https://doi.org/10.1253/jcj.61.927
Shinmura, Ken ; Tani, Masato ; Suganuma, Yukako ; Hasegawa, Hiroshi ; Ebihara, Yoshinori ; Nakamura, Yoshiro ; Asakura, Yasushi. / Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury. In: Japanese Circulation Journal. 1997 ; Vol. 61, No. 11. pp. 927-935.
@article{a50485437c8644b49c6e53cb9d34f9fc,
title = "Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury",
abstract = "To clarify the roles of subclasses of α1-adrenoreceptors in ischemic- reperfused myocardium, we compared the effect of the nonselective α1- blocker bunazosin with that of the α(1A)-blocker WB4101 and the α(1B)- blocker chlorethylclonidine (CEC) in isolated rat hearts. After 30 min of preperfusion, Langendorff-perfused hearts were subjected to 25 min of global ischemia followed by 30 min of reperfusion. Hearts were randomly divided into 4 groups, with one of the following substances being added to the perfusate: buffer alone (control), 10-6 mol/L bunazosin, 10-7 mol/L WB4101, or 10- 7 mol/L CEC. Bunazosin had a negative inotropic effect and preserved the postischemic ATP content, reduced the postischemic increase in intracellular Na+ content and then enhanced postreperfusion recovery of creatine phosphate. Bunazosin also reduced myocardial 45Ca2+ uptake during reperfusion (control 5.2 vs bunazosin 2.5 μmol/g dry weight of tissue (dwt), p<0.01). However, the recovery of left ventricular developed pressure (DP) was not improved when bunazosin was added to the perfusate during reperfusion. WB4101 had neither a negative inotropic nor an energy-sparing effect, but it improved the recovery of DP (control 43{\%} vs WB4101 56{\%} of preischemic value, p<0.05) with no reduction in myocardial 45Ca2+ uptake. CEC had a negative inotropic and energy-sparing effect and then reduced myocardial 45Ca2+ uptake (CEC 3.1 μmol/g dwt, p<0.05), but it did not improve the recovery of DP. These results suggest that the preischemic administration of an α(1B)-adrenoreceptor subtype blocker protected ischemic-reperfused myocardium via reduction of Ca2+ overload, whereas the selective blockade of the α(1A)-adrenoreceptor subtype reduced myocardial damage via mechanism(s) other than Ca2+ metabolism.",
keywords = "α-Adrenoreceptors, α-Subtype, Ca overload, Myocardial ischemia, Reperfusion injury",
author = "Ken Shinmura and Masato Tani and Yukako Suganuma and Hiroshi Hasegawa and Yoshinori Ebihara and Yoshiro Nakamura and Yasushi Asakura",
year = "1997",
month = "11",
doi = "10.1253/jcj.61.927",
language = "English",
volume = "61",
pages = "927--935",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "11",

}

TY - JOUR

T1 - Effects of α1-adrenoreceptor subtype blockade on ischemia-reperfusion injury

AU - Shinmura, Ken

AU - Tani, Masato

AU - Suganuma, Yukako

AU - Hasegawa, Hiroshi

AU - Ebihara, Yoshinori

AU - Nakamura, Yoshiro

AU - Asakura, Yasushi

PY - 1997/11

Y1 - 1997/11

N2 - To clarify the roles of subclasses of α1-adrenoreceptors in ischemic- reperfused myocardium, we compared the effect of the nonselective α1- blocker bunazosin with that of the α(1A)-blocker WB4101 and the α(1B)- blocker chlorethylclonidine (CEC) in isolated rat hearts. After 30 min of preperfusion, Langendorff-perfused hearts were subjected to 25 min of global ischemia followed by 30 min of reperfusion. Hearts were randomly divided into 4 groups, with one of the following substances being added to the perfusate: buffer alone (control), 10-6 mol/L bunazosin, 10-7 mol/L WB4101, or 10- 7 mol/L CEC. Bunazosin had a negative inotropic effect and preserved the postischemic ATP content, reduced the postischemic increase in intracellular Na+ content and then enhanced postreperfusion recovery of creatine phosphate. Bunazosin also reduced myocardial 45Ca2+ uptake during reperfusion (control 5.2 vs bunazosin 2.5 μmol/g dry weight of tissue (dwt), p<0.01). However, the recovery of left ventricular developed pressure (DP) was not improved when bunazosin was added to the perfusate during reperfusion. WB4101 had neither a negative inotropic nor an energy-sparing effect, but it improved the recovery of DP (control 43% vs WB4101 56% of preischemic value, p<0.05) with no reduction in myocardial 45Ca2+ uptake. CEC had a negative inotropic and energy-sparing effect and then reduced myocardial 45Ca2+ uptake (CEC 3.1 μmol/g dwt, p<0.05), but it did not improve the recovery of DP. These results suggest that the preischemic administration of an α(1B)-adrenoreceptor subtype blocker protected ischemic-reperfused myocardium via reduction of Ca2+ overload, whereas the selective blockade of the α(1A)-adrenoreceptor subtype reduced myocardial damage via mechanism(s) other than Ca2+ metabolism.

AB - To clarify the roles of subclasses of α1-adrenoreceptors in ischemic- reperfused myocardium, we compared the effect of the nonselective α1- blocker bunazosin with that of the α(1A)-blocker WB4101 and the α(1B)- blocker chlorethylclonidine (CEC) in isolated rat hearts. After 30 min of preperfusion, Langendorff-perfused hearts were subjected to 25 min of global ischemia followed by 30 min of reperfusion. Hearts were randomly divided into 4 groups, with one of the following substances being added to the perfusate: buffer alone (control), 10-6 mol/L bunazosin, 10-7 mol/L WB4101, or 10- 7 mol/L CEC. Bunazosin had a negative inotropic effect and preserved the postischemic ATP content, reduced the postischemic increase in intracellular Na+ content and then enhanced postreperfusion recovery of creatine phosphate. Bunazosin also reduced myocardial 45Ca2+ uptake during reperfusion (control 5.2 vs bunazosin 2.5 μmol/g dry weight of tissue (dwt), p<0.01). However, the recovery of left ventricular developed pressure (DP) was not improved when bunazosin was added to the perfusate during reperfusion. WB4101 had neither a negative inotropic nor an energy-sparing effect, but it improved the recovery of DP (control 43% vs WB4101 56% of preischemic value, p<0.05) with no reduction in myocardial 45Ca2+ uptake. CEC had a negative inotropic and energy-sparing effect and then reduced myocardial 45Ca2+ uptake (CEC 3.1 μmol/g dwt, p<0.05), but it did not improve the recovery of DP. These results suggest that the preischemic administration of an α(1B)-adrenoreceptor subtype blocker protected ischemic-reperfused myocardium via reduction of Ca2+ overload, whereas the selective blockade of the α(1A)-adrenoreceptor subtype reduced myocardial damage via mechanism(s) other than Ca2+ metabolism.

KW - α-Adrenoreceptors

KW - α-Subtype

KW - Ca overload

KW - Myocardial ischemia

KW - Reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=0030693288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030693288&partnerID=8YFLogxK

U2 - 10.1253/jcj.61.927

DO - 10.1253/jcj.61.927

M3 - Article

C2 - 9391860

AN - SCOPUS:0030693288

VL - 61

SP - 927

EP - 935

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 11

ER -